Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre.

Source:http://linkedlifedata.com/resource/pubmed/id/16413656

Download in:

View as

General Info

PMID
16413656